Guangdong Fuda Pharmaceutical Co., Ltd announced a private placement of shares of gross proceeds of CNY 50,000,000 on January 17, 2018. The transaction will include participation from Boya Bio-pharmaceutical Group Co., Ltd. (SZSE:300294) for the proceeds of CNY 35,400,000 and Liu Jianguo will invest CNY 14,600,000. Post the closing the registered capital of the company will increase from CNY 30,000,000 to CNY 80,000,000.